Ginkgo Bioworks Holdings, Inc. growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue: -40.5%
EBITDA: +45.6%
EBIT: +36.8%
EPS: +40.7%
Free cash flow: +46.9%
Operating cash flow: +41.1%

Forward estimates

Revenue: -37.3%
EBITDA: +58.0%
EPS: +54.9%

Three-year CAGR

Revenue: -29.1%
EBITDA: +47.4%
EBIT: +43.7%
Net income: +42.8%
EPS: +46.5%
Free cash flow: +53.2%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.